Boliden


The Swedish miner’s recovery gets a major shot in the arm

06/05/24 -"Boliden’s shares have been recovering well in the past few months. Moreover, last week’s news that the primary insurance claim for Rönnskär has been approved and operations at Tara, after successful ..."

Pages
68
Language
English
Published on
06/05/24
You may also be interested by these reports :
15/05/24
A mixed bag with a negative touch – Decline in sales and negative net profit

14/05/24
After rejecting BHP’s revised offer, Anglo has come up with a restructuring plan of its own. While the proposal seems like what BHP had wanted in the ...

11/05/24
Despite the downward revision of our short-term earnings forecasts, our valuation resets higher thanks to the expected rebound in nickel and ...

10/05/24
Although Norsk’s Q1 operating results marginally missed the street’s expectations, there were sequential improvements across the divisions – a ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO